Natural Products as Potential Therapeutic Candidates for Diabetic Kidney Disease: Molecular Mechanisms, Translational Challenges, and Future Prospects
International Journal of Molecular Sciences · 01.12.2025 · 26 (23) · 11637
DOI: 10.3390/ijms262311637 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 01.12.2025. Verfasst von Manqi Guo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Biological Products. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 225 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation of China, Outstanding Young and Middle-aged Talents Training Program of Zhongnan Hospital of Wuhan University, Translational Medicine and Interdisciplinary Research Joint Fund of Zhongnan Hospital of Wuhan University.
Abstract (Originalsprache)
Diabetic Kidney Disease (DKD) is one of the primary causes of chronic kidney disease. However, existing clinical interventions remain insufficiently effective in halting its progression, highlighting the need to explore novel therapeutic approaches. In recent years, natural products such as Abelmoschus manihot have shown growing potential in lowering urinary protein. Building on this background, this paper systematically summarizes preclinical evidence that certain natural substances ameliorate DKD by targeting key pathogenic mechanisms, including inflammation and oxidative stress. It also contrasts the pros and cons of natural medicines with existing therapies, while further investigating advanced pharmaceutical technologies for the translation of natural medicines into clinical applications. However, the clinical translation of natural medicines currently confronts multiple challenges, including small sample sizes, insufficient follow-up periods, individual heterogeneity, and insufficient accumulation of safety data. Therefore, future efforts should prioritize the in-depth exploitation of medicinal plant resources and their clinical translation, with a focus on enhancing high-quality translational clinical studies. This strategy seeks to provide novel insights and practical solutions for treating DKD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.
- Department of General Practice, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.
ORCID-Profile: Lihua Ni
Förderung
- the National Natural Science Foundation of China
- Outstanding Young and Middle-aged Talents Training Program of Zhongnan Hospital of Wuhan University
- Translational Medicine and Interdisciplinary Research Joint Fund of Zhongnan Hospital of Wuhan University
- Medical Science and Technology Innovation Platform Support Project of Zhongnan Hospital of Wuhan University
- Basic-Clinical Joint Construction Project of Wuhan Universit
- National Natural Science Foundation of China
- Basic–Clinical Joint Construction Project of Wuhan University
- Open Foundation of Hubei Provincial Key Laboratory of Tumor Microenvironment and Immunotherapy
Zitieren
APA
Guo, M., Ni, L., & Wu, X. (2025). Natural Products as Potential Therapeutic Candidates for Diabetic Kidney Disease: Molecular Mechanisms, Translational Challenges, and Future Prospects. International Journal of Molecular Sciences, 26(23), 11637. https://doi.org/10.3390/ijms262311637
Vancouver
Guo M, Ni L, Wu X. Natural Products as Potential Therapeutic Candidates for Diabetic Kidney Disease: Molecular Mechanisms, Translational Challenges, and Future Prospects. International Journal of Molecular Sciences. 2025;26(23):11637. doi:10.3390/ijms262311637
BibTeX
@article{Guo2025,
author = {Guo, Manqi and Ni, Lihua and Wu, Xiaoyan},
title = {Natural Products as Potential Therapeutic Candidates for Diabetic Kidney Disease: Molecular Mechanisms, Translational Challenges, and Future Prospects},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {23},
pages = {11637},
doi = {10.3390/ijms262311637}
}
EUVIMED